Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Charlotte Manisty et al.
LANCET (2021)
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
Maria Prendecki et al.
LANCET (2021)
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
Sharon Amit et al.
LANCET (2021)
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
Michael Marks et al.
LANCET INFECTIOUS DISEASES (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis et al.
NPJ VACCINES (2021)
Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
Todd Bradley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19
Riccardo Levi et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals
Alessio Mazzoni et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
The Untold Toll - The Pandemic's Effects on Patients without Covid-19
Lisa Rosenbaum
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients
Alessio Mazzoni et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors
Wee Chian Koh et al.
PLOS ONE (2020)
Covid-19 - Implications for the Health Care System (vol 383, pg 1483, 2020)
D. Blumenthal
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)